These Camp (formerly Cnlp) knock-out mice are more susceptible to bacterial infections and may be useful in studies of innate immune response, regulation of immune response, wound healing/angiogenesis and tumor development.
Richard L. Gallo, University of California at San Diego
The mouse Camp gene is an ortholog of the human gene CAMP, which encodes the precursor of cathelicidin antimicrobial peptide LL-37 (or CRAMP in mouse). Expressed mucosal epithelial cells, circulating neutrophils, and myeloid bone marrow cells, Camp is an essential part of the first line of defense against infection. In addition to antimicrobial activity, cathelicidin antimicrobial peptide plays a role in NK cell-mediated tumor growth suppression, and when secreted by neutrophils acts, as an attractant for monocytes, promoting wound healing or angiogenesis. Mouse CRAMP is implicated in adaptive immune response regulation and can interfere with TLR function via interactions with hyaluronan. Mice deficient in CRAMP are more susceptible to experimentally induced necrotic skin infection with Group A Streptococcus, urinary tract infection with uropathogenic E. coli, Pseudomonas aeruginosa infection, and meningococcal Neisseria meningitidis infection. Skin lesions, due to Group A Streptococcus infection, are larger and persist longer in homozygotes when compared to controls. Heterozygotes exhibit an intermediate Group A Streptococcus bacterial susceptibility phenotype. Within 1 hour of infection, more uropathogenic E. coli bacteria are attached to urinary bladder mucosa of mutant mice. 48 hours after infection, the number of bacteria in the urinary tract of homozygous mice is higher than wildtype controls. Mutant mice challenged with uropathogenic E. coli developed more severe urinary tract infections and exhibit higher mortality from septicemia when compared to controls. After intranasal Pseudomonas
aeruginosa inoculation, CRAMP deficient mice exhibit significantly higher levels of bacterial CFUs compared to controls. When pretreated with flagellin, only one third of infected CRAMP deficient mice survived, compared to complete survival of all infected wildtype mice. Homozygotes also develop more severe infection of Pseudomonas aeruginosa in induced corneal keratitis. An increased invasion rate is observed after oral administration of Listeria monocytogenes to homozygotes. In an experimentally induced skin inflammation model for atopic dermatitis, homozygotes exhibit enhanced swelling and more severe epidermal hypertrophy. The epidermal permeability barrier is functionally impaired in homozygotes. Induced irritation of the skin of homozygous mice by stratum corneum tryptic enzyme or physical abrastion results in reduced inflammatory infiltrate, when compared to controls. In vaccinia virus skin infection (eczema vaccinatum), homozygotes on the BALB/c background have higher levels of virus replication in skin biopsies compared to controls. Knock out mice are more susceptible to meningococcal Neisseria meningitidis infection with higher CFU load and mortality rate. When B and T cells from homozygotes are cultured in Th2-inducing conditions, the mutant B cells produce less IgG1 and IgE, and a higher ratio of mutant IL-4+ T cells is observed, when compared to cultures isolated from wildtype mice. Xenograft tumors growth is accelerated in homozygotes: B16.F10 melanoma tumors grow faster and obtain a larger size, and RMA-S lymphoma cell tumor development is earlier when compared to controls. NK cells isolated from homozygotes display defective cytotoxic activity. Mice that are homozygous for the targeted mutation are viable, fertile, normal in size and do not display any gross physical or behavioral abnormalities. No gene product (mRNA or protein) is detected by Northern blot analysis of bone marrow or by Western blot analysis of epidermis from homozygotes.
A targeting vector containing a PGK-neo cassette was used to disrupt exons 3 and 4. The construct was electroporated into unspecified 129X1/SvJ derived embryonic stem (ES) cells. Correctly targeted ES cells were injected into C57BL/6 blastocysts. The resulting chimeric animals were crossed to 129/SvJ female mice, and then backcrossed to C57BL/6J for seven generations. Upon arrival at The Jackson Laboratory, the mice were crossed to C57BL/6J (Stock No. 000664) at least once to establish the colony.
|Allele Name||targeted mutation 1, Richard L Gallo|
|Allele Type||Targeted (Null/Knockout)|
|Allele Synonym(s)||Camp-; Cnlp-; Cnlp-null; Cramp-ko|
|Gene Symbol and Name||Camp, cathelicidin antimicrobial peptide|
|Strain of Origin||129X1/SvJ|
|Molecular Note||Exons 3 and 4, which encode the entire mature domain of the protein, were replaced with a PGK-neo cassette via homologous recombination. Northern blot analysis using a probe to exon 4 confirmed the absence of gene expression in bone marrow of homozygous mutant animals.|
|Mutations Made By|| |
Carlos Aguilera, University of California at San Diego
When maintaining a live colony, these mice can be bred as homozygotes.
When using the CRAMP KO mouse strain in a publication, please cite the originating article(s) and include JAX stock #017799 in your Materials and Methods section.
"MICE" means mouse strains, their progeny derived by inbreeding or crossbreeding, unmodified derivatives from mouse strains or their progeny supplied by The Jackson Laboratory ("JACKSON"). "PRODUCT(S)" means biological materials supplied by JACKSON, and their derivatives. "SERVICES" means projects conducted by JACKSON for other parties that may include but are not limited to the use of MICE or PRODUCTS. "RECIPIENT" means each recipient of MICE, PRODUCTS, or SERVICES provided by JACKSON including each institution, its employees and other researchers under its control. MICE or PRODUCTS shall not be: (i) used for any purpose other than internal research, (ii) sold or otherwise provided to any third party for any use, or (iii) provided to any agent or other third party to provide breeding or other services. Acceptance of MICE, PRODUCTS or SERVICES from JACKSON shall be deemed as agreement by RECIPIENT to these conditions, and departure from these conditions requires JACKSON’s prior written authorization.
MICE, PRODUCTS AND SERVICES ARE PROVIDED "AS IS". JACKSON EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of, PRODUCTS or SERVICES, JACKSON will, at its option, provide credit or replacement for the PRODUCT received or the SERVICES provided; JACKSON makes no other representations and this shall be the exclusive remedy of the purchaser. Please note specific policy for live mice.
Consistent with the requirement for a written understanding regarding animal care and use, the JACKSON Animal Care and Use Committee will review the animal care and use protocol(s) associated with any SERVICES to be performed at JACKSON, and JACKSON shall have ultimate responsibility and authority for the care of animals while on site or in JACKSON custody.
In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS, or SERVICES, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. Unless prohibited by law, in purchasing or receiving MICE, PRODUCTS, or SERVICES from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.
MICE, PRODUCTS or SERVICES are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or SERVICES. In addition, special terms and conditions of sale of certain MICE, PRODUCTS, or SERVICES may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and SERVICES by JACKSON, and by its licensees and distributors.
Acceptance of delivery of MICE, PRODUCTS or SERVICES shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or SERVICES by JACKSON.